Alto Neuroscience (ANRO) Common Equity (2023 - 2026)
Alto Neuroscience (ANRO) posted Common Equity of $219.25 million for Q2 2026, up 77.7% from $123.41 million a year earlier but down 9.9% from the prior quarter.
Powered by 
Analysis
Alto Neuroscience (ANRO) Common Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Alto Neuroscience's Common Equity came in at $151.14 million, down 0.2% from FY2024.
- In prior years, Alto Neuroscience's Common Equity was $151.46 million in FY2024 and -$71.67 million in FY2023.
- Quarterly Common Equity has run from a low of -$71.67 million in Q4 2023 to a high of $243.37 million in Q1 2026 over five years.
- On a year-over-year basis, Common Equity increased in two of the last six quarters, with growth averaging 10.1%.
- According to Business Quant data, Common Equity for the three prior quarters was $243.37 million (Q1 2026), $151.14 million (Q4 2025) and $111.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Alto Neuroscience | 999.68 Mn | 177.89 Mn | - | 219.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 219.25 Mn |
| Mar 31, 2026 | 243.37 Mn |
| Dec 31, 2025 | 151.14 Mn |
| Sep 30, 2025 | 111.56 Mn |
| Jun 30, 2025 | 123.41 Mn |
| Mar 31, 2025 | 139.10 Mn |
| Dec 31, 2024 | 151.46 Mn |
| Sep 30, 2024 | 165.05 Mn |
| Jun 30, 2024 | 179.78 Mn |
| Mar 31, 2024 | 193.10 Mn |
| Dec 31, 2023 | -71.67 Mn |
| Sep 30, 2023 | -61.10 Mn |
| Jun 30, 2023 | -52.60 Mn |
| Mar 31, 2023 | -45.23 Mn |
API Access
Alto Neuroscience Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ANRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ANRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ANRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();